A high-volume journal on brain and spinal cord tumours, from glioma biology to surgery, radiotherapy and drug trials. Read by neuro-oncologists, neurosurgeons and brain tumour researchers.
The Journal of Neuro-Oncology is published by Springer Nature and catalogued by NLM from 1983 as a United States journal, now at fifteen issues a year after starting as a quarterly, indexed for MEDLINE under Nervous System Neoplasms. The publisher describes it as a multidisciplinary journal encompassing basic, applied and clinical investigations in all research areas as they relate to cancer and the central nervous system. It lists a hybrid publishing model, with subscription access and an open access option; the journal is not listed in the Directory of Open Access Journals. Not to be confused with Neuro-Oncology, the Society for Neuro-Oncology journal published by Oxford University Press, which has its own record in this corpus.
Shares Craniopharyngioma, Ependymoma, Atypical teratoid/rhabdoid tumour (ATRT), Diffuse midline glioma, H3 K27-altered (including DIPG).
Shares Craniopharyngioma, Ependymoma, Atypical teratoid/rhabdoid tumour (ATRT), Diffuse midline glioma, H3 K27-altered (including DIPG).
Shares Neuro-Oncology, Atypical teratoid/rhabdoid tumour (ATRT).
Shares Primary CNS lymphoma, Medulloblastoma, Glioma & glioblastoma.